Breast Cancer Core Needle Biopsy Market Benefits from Increased Awareness and Rapid Adoption of Image-Guided Biopsy Systems

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Breast Cancer Core Needle Biopsy Market - (By Technology (MRI-based Breast Biopsy, Ultrasound-based Breast Biopsy, Mammography-based (Stereotactic) Breast Biopsy, CT-based Breast Biopsy, Other Image Based Breast Biopsy), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Breast Cancer Core Needle Biopsy Market is valued at US$ 697.3 Mn in 2023, and it is expected to reach US$ 1,042.3 Mn by 2031, with a CAGR of 5.34% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2310

Core needle biopsies offer several advantages over traditional surgical methods, including reduced invasiveness, shorter recovery times, and greater cost-efficiency. These benefits, coupled with their critical role in early disease detection and improved patient outcomes, are contributing to the anticipated growth of the core needle biopsy market. The increasing global emphasis on early diagnosis of health conditions is further driving market demand. During the biopsy procedure, tissue or fluid samples are obtained for microscopic examination to detect the presence of cancerous or other abnormal cells.

In addition, technological advancements and innovations in breast biopsy devices are supporting market expansion. However, the high costs associated with breast biopsy procedures, along with the potential for adverse side effects, may hinder broader adoption. The rising incidence of breast cancer globally has created new opportunities for vendors to promote advanced diagnostic solutions. Leading market players are actively pursuing product diversification and regulatory approvals to strengthen their market positions. Educational initiatives, including medical conferences and awareness campaigns, play a key role in informing the public about cancer detection and prevention, thereby supporting market growth.

List of Prominent Players in the Breast Cancer Core Needle Biopsy Market:
• Intact Medical Corporation
• Ethicon Surgical Technologies.
• Galling SRL
• Leica Biosystems Nussle GmbH
• Hologic, Inc
• Argon Medical Devices
• Encapsule Medical Devices LLC.
• Cook Medical Incorporated
• Becton Dickinson and Company
• C.R. Bard, Inc.
• Zenalux Biomedical, Inc.,
• F. Hoffmann-La Roche Ltd.,
• OncoCyte Corporation,
• Laboratory Corporation of America Holdings (LabCorp),
• Scion Medical Technologies,
• Planmed Oy,
• Aurora Imaging Technology Inc.,
• Carestream Health,
• Cardinal Health,
• PerkinElmer
• QIAGEN
• Thermo Fisher Scientific
• Medtronic
• Danaher Corporation
• Others

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Market Dynamics
Drivers:
The rising incidence of breast cancer and advancements in imaging and biopsy technologies are key factors propelling the growth of the breast biopsy instrument market. Technological innovations have significantly enhanced the precision, efficiency, and reliability of breast biopsy procedures, contributing to increased adoption rates. However, the market's expansion may face constraints due to the high cost of procedures and the potential for adverse side effects. As breast cancer cases continue to increase globally, the importance of strategic promotional efforts by vendors has grown. Leading market participants are focused on diversifying their product portfolios and securing regulatory approvals to strengthen their competitive positioning. Additionally, platforms such as medical conferences are being utilized to raise awareness and educate stakeholders on breast cancer diagnostics.

Challenges:
Despite the advantages of core needle biopsy, the technique faces certain limitations. One major concern is the potential for sampling errors and inconclusive results, which can be influenced by factors such as tumor size and location, possibly leading to false negatives. Patient discomfort and procedural anxiety may also hinder widespread acceptance, particularly in cases where the biopsy is clinically recommended. Economic constraints represent another significant challenge. The overall cost of core needle biopsy procedures-including equipment, skilled personnel, and post-procedural care-can limit accessibility, especially in regions with under-resourced healthcare systems.

Regional Trends:
North America is projected to hold a dominant position in the breast cancer core needle biopsy market, primarily driven by the United States and Canada. These countries contribute significantly to regional market revenue, supported by robust healthcare infrastructure and growing medical tourism. The Asia-Pacific region is also witnessing substantial growth. Rapid advancements in healthcare infrastructure across emerging economies such as China, India, and South Korea have spurred market expansion. Increased public awareness regarding breast cancer diagnostics, along with growing investments in advanced technologies-such as vacuum-assisted biopsy systems and liquid biopsy techniques-are enabling broader access to diagnostic tools and creating new opportunities for market penetration in the region.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2310

Recent Developments:
• In Jan 2021, Somatex Medical Technologies GmbH, a market leader in biopsy site markers and localization technologies, was acquired by Hologic, Inc. for an estimated $64 million, the company disclosed this morning. Hologic's approach to offering an all-encompassing collection of groundbreaking solutions spanning the entire spectrum of breast health care was reinforced by the transaction.

Segmentation of Breast Cancer Core Needle Biopsy Market-
By Technology
• MRI-based Breast Biopsy
• Ultrasound-based Breast Biopsy
• Mammography-based (Stereotactic) Breast Biopsy
• CT-based Breast Biopsy
• Other Image Based Breast Biopsy
By End-use
• Hospitals & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes"
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/breast-cancer-core-needle-biopsy-market/2310

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.